Cargando…

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer

BACKGROUND: Endometrial cancer (EnCa) ranks fourth in menace within women’s malignant tumors. Large numbers of studies have proven that functional genes can change the process of tumors by regulating the cell cycle, thereby achieving the goal of targeted therapy. METHODS: The transcriptional data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinhui, Mei, Jie, Li, Siyue, Wu, Zhipeng, Zhang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372883/ https://www.ncbi.nlm.nih.gov/pubmed/32699528 http://dx.doi.org/10.1186/s12935-020-01428-z

Ejemplares similares

Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma
por: Liu, JinHui, et al.
Publicado: (2020)

Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
por: Wang, Hui, et al.
Publicado: (2020)

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
por: Liu, JinHui, et al.
Publicado: (2020)

Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis
por: Liu, JinHui, et al.
Publicado: (2019)

Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2021)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer
por: Wang, Zi-Hao, et al.
Publicado: (2019)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021)

Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
por: Liu, Jiahua, et al.
Publicado: (2021)

Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient
por: Tang, Jia, et al.
Publicado: (2019)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: Zhou, Xin-Ying, et al.
Publicado: (2022)

Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis
por: Hu, Gang, et al.
Publicado: (2020)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Establishing a Prognostic Signature Based on Epithelial–Mesenchymal Transition-Related Genes for Endometrial Cancer Patients
por: Liu, Jinhui, et al.
Publicado: (2022)

Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021)

Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis
por: Chen, Qian, et al.
Publicado: (2021)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer
por: Sun, Rui, et al.
Publicado: (2021)

A novel risk score system of immune genes associated with prognosis in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: International, BioMed Research
Publicado: (2022)

Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer
por: Hu, Wei, et al.
Publicado: (2021)

Identification of a 6-gene signature predicting prognosis for colorectal cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qqsnsjakgfv49dvk1tka4bv6fo